Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19

Sponsor
Ramos Mejía Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05248243
Collaborator
(none)
41
1
35.8
1.1

Study Details

Study Description

Brief Summary

Respiratory failure associated with Covid-19 can be expressed as acute respiratory distress syndrome (ARDS), which is an acute inflammatory lung injury,which generally requires the use of invasive mechanical ventilation (MV). There are inconclusive results regarding the potential lung recruitment in ARDS. Recently, a new index based on lung compliance has been described to directly quantify the potential for lung recruitment, called the recruitment-inflation index (R/I index). The objective of this study is to prospectively evaluate the recruitment capacity in patients with ARDS and ARDS-Covid-19.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Recruitment assessment

Detailed Description

During the first 7 days of the patient on mechanical ventilation (MV), measurements will be taken. For this, the patient will be in the supine position (DS) or the prone position (DP). The patient will be on a dose of analgesics, under sedation and muscle relaxation and will not present any respiratory stimulus.

Data from MV will also be recorded (prior to recruitment assessment): tidal volume (TV) in milliliters (ml), respiratory rate (RR) in a minute, fraction of inspired oxygen (FiO2), positive end-expiratory pressure (PEEP), in centimeters of water (cmH2O), plateau pressure (Pplat, measured after an end-inspiratory pause, cmH2O), mean airway pressure (PM, cmH2O), minute volume (calculated as the product of RR and TV) in milliliters per minute, ∆P (calculated as Pplat minus PEEP, cmH2O), static compliance (calculated as TV divided by ∆P, ml/cmH2O). Arterial blood gases will also be considered. The proposed recruitment assessment (R/I index) will be compared with another already validated method to evaluate recruitment, such as the measurement of pulmonary hysteresis ratio.For measurements, a ventilator (Neumovent GraphNet Advance-TS, Córdoba Argentina) will be used. Additionally, a dedicated software connected to a computer will be used to perform the measurements.

The following will be assessed: presence of autoPEEP, preset inspiratory tidal volume (TVi), TV exhaled by the ventilator (TVexh) and TV exhaled from high to low PEEP (difference of 10 cm of H2O),during a single maneuver (TVeHL). The measurement will be performed with a high level of PEEP (PEEPH), with values between 15 and 18 cmH2O and a low level of PEEP (PEEPL) with values between 5 and 8 cmH2O. Pplat in PEEPL will also be measured. Additionally, an attempt will be made to determine if there is complete airway closure (a confounder for measurement of alveolar pressure). This is because there are patients who have complete airway closure. In this case, the lungs required an airway opening pressure (AOP) to reopen airways before initiating lung inflation. When AOP is higher than PEEPL, the AOP will be considered as the lower pressure value (instead of PEEPL).

The recruitment index (R/I index) will be as follows:

R/I = (TVexHL - TVexH)/TVi X (Ppl - PEEPL/PEEPH - PEEPL) - 1

TVexH: TV exhaled with PEEPH.

In case of airway closure PEEPL will be replaced by AOP.

A threshold of 0.5 was used to define high recruitability (R/I ratio >= 0.5) and low recruitability (R/I ratio < 0.5).

The evaluation of pressure in relation to volume will also be carried out, through the pressure/volume curve (PV curve), available in the respirator. A low-flow inflation and deflation PV curve from 0 up to 40 cm H2O and from 40 down to 0 cm H2O will be performed using the automatic tool on the ventilator (P/V tool; Neumovent GraphNet Advance-ts, Córdoba Argentina). The P-V curve can be visualized immediately on the screen of the mechanical ventilator and will be taken as a reference method to assess lung recruitment through the hysteresis-like behavior of the respiratory system. Inflation and deflation volume data will be corrected for changes in oxygen consumption.

Ratio hysteresis of the respiratory system will be measured by planimetry using SigmaPlot 12.0 software. There, through a cursor, for the measurement of hysteresis, the place where the volume was greater was drawn and the coincident pressure value was considered. Subsequently the ratio hysteresis was calculated as the ratio between hysteresis and the product of the pressure span and the maximum volume reached (maximum hysteresis). Recruitment potential will be considered if this relationship presents a value > 28%.

Data Analysis. Categorical variables will be presented as number and percentage, while continuous variables will be presented as mean and standard deviation or median and interquartile range, as appropriate. The Chi2 test or Fisher's exact test will be used for qualitative variables and the Student test or the Mann-Whitney U test for quantitative variables. To evaluate correlation, the Pearson or Spearman test will be used, according to the distribution of the evaluated variables. A p ≤ 0.05 will be used.

Study Design

Study Type:
Observational
Anticipated Enrollment :
41 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
Actual Study Start Date :
Mar 7, 2022
Actual Primary Completion Date :
Mar 7, 2022
Anticipated Study Completion Date :
Mar 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Potential recruitment of patients with ARDS and ARDS-Covid-19 [First 7 days of the patient on mechanical ventilation (MV)]

    To determine the Recruitment Index (R/I) of patients with ARDS and ARDS-Covid-19. Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O. A threshold of 0.5 will be used to define high recruitability (R/I ratio >= 0.5 ml/cmH2O) and low recruitability (R/I ratio < 0.5 ml/cmH2O).

Secondary Outcome Measures

  1. To compare the potential recruitment in the supine position (SD) and in the prone position (PD). [First 7 days of the patient on mechanical ventilation (MV)]

    To compare the R/I (ml/cmH2O) in patients with ARDS and ARDS-Covid-19 in the supine position (SD) and in the prone position (PD). Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O. A threshold of 0.5 will be used to define high recruitability (R/I ratio >= 0.5 ml/cmH2O) and low recruitability (R/I ratio < 0.5 ml/cmH2O).

  2. Correlation between recruitment index (RI) and recruitment assessed by hysteresis ratio. [First 7 days of the patient on mechanical ventilation (MV)]

    Assess the correlation between recruitment index (RI) and recruitment assessed by the hysteresis ratio (hysteresis and the product of the pressure span and the maximum volume reached (maximum hysteresis) in ml/cmH2O Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O. Tidal volume and pressure will be combined to report the hysteresis ratio in mL/cmH2O.

  3. Assess the relationship between potential recruitment with respiratory parameters. [First 7 days of the patient on mechanical ventilation (MV)]

    Assess the correlation between IR and respiratory parameters Oxygenation: PaO2/FiO2 (ratio between arterial oxygen pressure and inspired fraction of oxygen). Static compliance (cmH2O) Plateau pressure (cmH2O) ∆P (ml/cmH2O) Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

  4. Assess the relationship between potential recruitment and clinical parameters. [First 7 days of the patient on mechanical ventilation (MV)]

    Assess the correlation between IR and clinical parameters: Symptom onset date (FIS) (in case of ARDS-Covid-19) APACHE II (Acute Physiology And Chronic Health Evaluation) score SOFA (Sequential Organ Failure Assessment Score) score Ventilator free days (in days) Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who have been receiving MV with diagnosis of ARDS (Berlin definition) and ARDS-Covid-19.
Exclusion Criteria:
  • Patients with chronic pulmonary disease

  • Patients with a high risk of death within 3 months for reasons other than ARDS-Covid-19

  • Patients having made the decision to withhold life-sustaining treatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Agudos Ramos Mejía Ciudad Autonoma de Buenos Aire Buenos Aires Argentina C1221ADC

Sponsors and Collaborators

  • Ramos Mejía Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Roberto Santa Cruz, Principal Investigator, Ramos Mejía Hospital
ClinicalTrials.gov Identifier:
NCT05248243
Other Study ID Numbers:
  • Hospital General Ramos Mejía
First Posted:
Feb 21, 2022
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2022